SCYNEXIS to Present SCY-078 Data at ASM Microbe 2018

JERSEY CITY, N.J. , May 24, 2018 /PRNewswire/ —  SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced three poster presentations at American Society for Microbiology (ASM) Microbe 2018,

READ FULL TEXT

Leave a Reply

Your email address will not be published.